GEODE CAPITAL MANAGEMENT, LLC
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1214717
BOSTON, MA
Position in ARCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,661,395
-$440,968 QoQ
Shares Held
693,660
+5.0% QoQ
Ownership
2.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 133 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ARCT ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ARCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,661,395 | 693,660 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,102,363 | 660,928 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,789,160 | 618,134 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $11,275,897 | 611,823 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,887,845 | 606,291 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $6,032,275 | 569,620 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,418,077 | 554,984 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,807,231 | 551,798 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $13,295,318 | 546,009 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $18,582,381 | 550,263 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $16,971,495 | 538,265 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,085,892 | 512,168 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,201,647 | 495,176 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,220,740 | 468,116 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,630,965 | 449,939 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,176,842 | 416,791 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,178,532 | 392,537 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,001,701 | 370,983 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $13,882,932 | 375,113 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,129,630 | 400,369 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,981,599 | 383,617 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $14,698,504 | 355,896 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $14,072,298 | 324,396 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $11,563,007 | 269,534 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,918,274 | 212,201 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,202,538 | 88,487 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||